Actively Recruiting
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Led by Kochi University · Updated on 2022-03-07
500
Participants Needed
1
Research Sites
626 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.
CONDITIONS
Official Title
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Elective pancreatectomy planned for pancreatic cancer
You will not qualify if you...
- Previous cancer surgery
- Body weight loss of more than 10% in the 6 months before surgery
- Presence of distant metastases
- Serious impairment of lung, kidney, or heart function
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Takehiro Okabayashi
Kochi, Japan, 781-8555
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here